ErlySign - About the company
ErlySign is a seed company based in Nagpur (India), founded in 2019 by Shubhendrasingh Jitendrasingh Thakur and Deovrat Begde. It operates as a Provider of a saliva-based, non-invasive oral cancer detection platform. ErlySign has raised $2.17M in funding from LVX and Laxmi investments FZCO, with a current valuation of $*****. The company has 1489 active competitors, including 179 funded and 174 that have exited. Its top competitors include companies like Abcam, Molbio Diagnostics and Quanterix.
Company Details
Provider of a saliva-based, non-invasive oral cancer detection platform. It develops rapid screening solutions designed to identify oral cancer at its earliest stages, enabling timely diagnosis and improved clinical outcomes. Its technology is deployed across hospitals, diagnostic laboratories, and dental clinics, helping healthcare providers expand preventive screening programs, increase early-stage detection rates, and enhance patient care.
- Website
- erlysign.com
- Social
- Email ID
- *****@erlysign.com
- Phone Number
- +91 **********
- Registered Address
- Plot No. 41, H.No. 1408/A, DARSHANA SOCIETY, MOUJA GOREWADA, Nagpur, NAGPUR, Maharashtra, India, 440013
Key Metrics
Founded Year
2019
Location
Nagpur, India
Stage
Seed
Total Funding
$2.17M in 5 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 26, 2024
Ranked
121st among 1489 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
14 as on Aug 31, 2026
Similar Companies
Legal entities associated with ErlySign
ErlySign is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
CURO BIOSCIENCES PRIVATE LIMITED CIN: U85300MH2019PTC329302 , India, Active | Aug 14, 2019 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download ErlySign's company profile
ErlySign's funding and investors
ErlySign has raised a total funding of $2.17M over 5 rounds. Its first funding round was on 2019. Its latest funding round was a Seed round on Dec 26, 2024 for $*****. 2 investors participated in its latest round. ErlySign has 9 institutional investors and 5 angel investors.
Here is the list of recent funding rounds of ErlySign:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 26, 2024 | 1759444 | Seed | 9871304 | 6833552 | 4878036 | 8106043 |
Jun 26, 2023 | 3908775 | Seed | 4715090 | 4129131 | 6225157 | 9131817 |
2023 | 5275 | Grant (prize money) | 5538 | 2378 | 6609 |
Access funding benchmarks and valuations. Sign up today!View details of ErlySign's funding rounds and investors
ErlySign's founders and board of directors
Founder? Claim ProfileThe founders of ErlySign are Shubhendrasingh Jitendrasingh Thakur and Deovrat Begde. Shubhendrasingh Jitendrasingh Thakur is the CEO of ErlySign.
Here are the details of ErlySign's key team members:
- Shubhendrasingh Jitendrasingh Thakur: Co-Founder & CEO of ErlySign. They serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
- Deovrat Begde: Co-Founder & Chief Scientific Officer of ErlySign. Contact Info: 1 email address
ErlySign's Board of Directors
ErlySign's board has 2 active members. Shubhendrasingh Jitendrasingh Thakur is part of team and Pradnya Anil Mahatme is independent board member.Here is the list of ErlySign's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 1m | |
Independent board member | - | Current | 4y 5m |
View details of ErlySign's Founder profiles and Board Members
ErlySign's employee count trend
ErlySign has 14 employees as of Aug 26. Here is ErlySign's employee count trend over the years:
Uncover ErlySign's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ErlySign's Competitors and alternates
Top competitors of ErlySign include Abcam, Molbio Diagnostics and Quanterix. Here is the list of Top 10 competitors of ErlySign, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Molbio Diagnostics 2000, Salcete (India), Public | Developer of point-of-care molecular diagnostic platform for infectious disease detection | $124M | 74/100 | |
3rd | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 71/100 | |
4th | Fulgent Genetics 2011, Temple City (United States), Acquired | Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer | $34.8M | - | 71/100 |
5th | Invitae 2010, San Francisco (United States), Public | Provider of home-based genetic test for individuals | $190M | 68/100 | |
6th | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
7th | Provider of precision oncology solutions, including genomic testing and digital health | $25.9M | 67/100 | ||
8th | Qiagen 1984, Venlo (Netherlands), Acquired | Provider of products and reagents for molecular diagnostic assays | - | 65/100 | |
9th | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
10th | LGC 1842, Teddington (United Kingdom), Acquired | Provider of analytical testing, reference materials, and diagnostic and therapeutic products | - | 65/100 | |
121st | Provider of a saliva-based, non-invasive oral cancer detection platform | $2.17M | 42/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ErlySign's competitors? Click here to see the top ones
ErlySign's Investments and acquisitions
ErlySign has made no investments or acquisitions yet.
Reports related to ErlySign
Here is the latest report on ErlySign's sector:
News related to ErlySign
•
•
ErlySign has raised INR 16 Cr in Pre-Series A funding from Ashish Kacholia.Enablers•Jan 13, 2025•ErlySign
•
How Erly Sign As A Biotech Startup Is Changing The Face of Cancer DiagnosisKeeVurds•Mar 01, 2022•ErlySign
•
Lumos Health Accelerator onboards startups in early cancer detection and advanced cancer prognosticsAsian News International•Apr 12, 2021•ErlySign, Lumos Health, Onward Assist
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about ErlySign
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
